BOT - Anything but charting, page-9913

those are crazy numbers - but reflects the potential of the market.

even capturing 5% of diagnosed would return $1B revenue and assume 40% EBITDA. its a real cash cow. I dont know how to calculate share price estimates on the back of scenarios, but those numbers would indicate market cap potential value of 4B+ plus if we assume 10X EBITDA multiple.

lot of upside potential here on share price, only concern is whether there is a decent chunk of the target market that is willing and able to afford $500 USD a month and how much of it is offset by insurance or healthcare rebate (ie what is out of pocket for the consumer)